4.7 Article

α-Tocopherol Pharmacokinetics in Adults with Cystic Fibrosis: Benefits of Supplemental Vitamin C Administration

相关参考文献

注意:仅列出部分参考文献,下载原文获取全部文献信息。
Article Critical Care Medicine

Clinical Effectiveness of Elexacaftor/Tezacaftor/Ivacaftor in People with Cystic Fibrosis

David P. Nichols et al.

Summary: The study demonstrates significant improvements in lung function, respiratory symptoms, and body mass index in CF patients using ETI therapy, regardless of their familiarity with modulators or prior drug use. Significant reductions in sweat chloride concentration were also observed, correlating with improved lung function in the overall study population.

AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2022)

Article Nutrition & Dietetics

Determination of tissue-specific interaction between vitamin C and vitamin E in vivo using senescence marker protein-30 knockout mice as a vitamin C synthesis deficiency model

Ayami Sato et al.

Summary: The study revealed that in SMP30-KO mice, vitamin C mainly spares vitamin E in the liver and heart, while vitamin E spares vitamin C in the kidneys. The interaction between vitamin C and vitamin E is likely to be tissue specific.

BRITISH JOURNAL OF NUTRITION (2022)

Review Critical Care Medicine

IV Vitamin C in Critically Ill Patients: A Systematic Review and Meta-Analysis

Jayshil J. Patel et al.

Summary: Based on a systematic review and meta-analysis, the administration of IV vitamin C in critically ill patients may be associated with a trend toward reduction in overall mortality. High-dose IV vitamin C monotherapy may be associated with improved overall mortality, while low-dose IV vitamin C and combination therapy with other treatments have no effect. IV vitamin C appears to be safe, and further randomized controlled trials are needed for validation.

CRITICAL CARE MEDICINE (2022)

Article Respiratory System

Worldwide rates of diagnosis and effective treatment for cystic fibrosis

Jonathan Guo et al.

Summary: This study identifies gaps in access to cystic fibrosis (CF) treatment, particularly in low- and middle-income countries. The results reveal a significant burden of undiagnosed or untreated CF patients in many countries where disease-modifying drugs are unavailable.

JOURNAL OF CYSTIC FIBROSIS (2022)

Review Pharmacology & Pharmacy

Efficacy and Safety of Triple Combination Cystic Fibrosis Transmembrane Conductance Regulator Modulators in Patients With Cystic Fibrosis: A Meta-Analysis of Randomized Controlled Trials

Yizi Wang et al.

Summary: Triple combination therapy for cystic fibrosis patients achieves better clinical results and comparable adverse events compared to the control group.

FRONTIERS IN PHARMACOLOGY (2022)

Article Biochemistry & Molecular Biology

Links between Disease Severity, Bacterial Infections and Oxidative Stress in Cystic Fibrosis

Sabina Galiniak et al.

Summary: Cystic fibrosis patients experience significant oxidative stress, which increases with disease severity and varies according to the type of bacterial infection.

ANTIOXIDANTS (2022)

Article Respiratory System

Worldwide rates of diagnosis and effective treatment for cystic fibrosis

Jonathan Guo et al.

Summary: This study aims to identify gaps in access to cystic fibrosis (CF) treatment globally. The findings suggest that in some countries, disease-modifying drugs are not available, leading to unmet needs among CF patients. The study highlights the potential to improve diagnosis and treatment rates for CF.

JOURNAL OF CYSTIC FIBROSIS (2022)

Article Biochemistry & Molecular Biology

From fat to bilayers: Understanding where and how vitamin E works

Jeffrey Atkinson et al.

Summary: Vitamin E was one of the last fat-soluble vitamins discovered, and it plays important roles as an antioxidant and structural component in phospholipid bilayer membranes. Despite our detailed understanding of the orientation and dynamics of alpha-tocopherol in lipid bilayers, gaps still exist in our knowledge regarding its effects and potential receptors in controlling gene transcription.

FREE RADICAL BIOLOGY AND MEDICINE (2021)

Article Biochemistry & Molecular Biology

Vitamin E: How much is enough, too much and why!

Maret G. Traber et al.

Summary: This narrative review focuses on the structures, functions, biological determinants, and deficiency symptoms of vitamin E in humans, discussing the mechanisms for alpha-T tissue enrichment, potential new biomarkers, pharmacokinetic data, and approaches to evaluate alpha-T dietary requirements. The possible role of alpha-T supplements in delaying chronic diseases and the evaluation of vitamin E safety are also considered in this review.

FREE RADICAL BIOLOGY AND MEDICINE (2021)

Article Physiology

CFTR Correctors and Antioxidants Partially Normalize Lipid Imbalance but not Abnormal Basal Inflammatory Cytokine Profile in CF Bronchial Epithelial Cells

Mieke Veltman et al.

Summary: In cystic fibrosis, a deficiency in CFTR function leads to chronic lung disease. Abnormalities in lipid metabolism and oxidative stress were observed in CF airway epithelium, indicating potential roles in CF lung pathology progression. Treatment with antioxidants or CFTR modulators may require a combination approach for correction of the CF phenotype.

FRONTIERS IN PHYSIOLOGY (2021)

Article Nutrition & Dietetics

Fat-Soluble Vitamin Supplementation Using Liposomes, Cyclodextrins, or Medium-Chain Triglycerides in Cystic Fibrosis: A Randomized Controlled Trial

Jan K. Nowak et al.

Summary: The study showed that liposomes could improve the bioavailability of vitamin A, while cyclodextrins could enhance the bioavailability of vitamins D3 and E. This may be beneficial for pancreatic-insufficient CF patients, but further research is needed.

NUTRIENTS (2021)

Review Critical Care Medicine

Measuring vitamin C in critically ill patients: clinical importance and practical difficulties-Is it time for a surrogate marker?

Sander Rozemeijer et al.

Summary: This article is one of ten reviews selected from the Annual Update in Intensive Care and Emergency Medicine 2021, offering insights into the latest developments and trends in intensive care and emergency medicine.

CRITICAL CARE (2021)

Review Pediatrics

A systematic Cochrane Review of antioxidant supplementation lung disease for cystic fibrosis

Oana Ciofu et al.

PAEDIATRIC RESPIRATORY REVIEWS (2020)

Article Biochemistry & Molecular Biology

α-Tocopherol Attenuates the Severity of Pseudomonas aeruginosa-induced Pneumonia

Brant M. Wagener et al.

AMERICAN JOURNAL OF RESPIRATORY CELL AND MOLECULAR BIOLOGY (2020)

Article Clinical Neurology

First Recognized Patient with Genetic Vitamin E Deficiency Stable after 36 Years of Controlled Supplement Therapy

Alfried Kohlschuetter et al.

NEURODEGENERATIVE DISEASES (2020)

Review Medicine, General & Internal

Vitamin E supplementation in people with cystic fibrosis

Peter O. Okebukola et al.

COCHRANE DATABASE OF SYSTEMATIC REVIEWS (2020)

Article Medicine, Research & Experimental

Vitamin E sequestration by liver fat in humans

Pierre-Christian Violet et al.

JCI INSIGHT (2020)

Review Respiratory System

Bile acid homeostasis in gastrointestinal and metabolic complications of cystic fibrosis

Ivo P. van de Peppel et al.

JOURNAL OF CYSTIC FIBROSIS (2019)

Review Respiratory System

Infection prevention and control in cystic fibrosis: a systematic review of interventions

Nicola J. Rowbotham et al.

EXPERT REVIEW OF RESPIRATORY MEDICINE (2019)

Article Biochemistry & Molecular Biology

Transcriptomic Responses to Ivacaftor and Prediction of Ivacaftor Clinical Responsiveness

Tao Sun et al.

AMERICAN JOURNAL OF RESPIRATORY CELL AND MOLECULAR BIOLOGY (2019)

Article Cell Biology

Endothelial Dysfunction in Cystic Fibrosis: Role of Oxidative Stress

Matthew A. Tucker et al.

OXIDATIVE MEDICINE AND CELLULAR LONGEVITY (2019)

Article Critical Care Medicine

Correlating Cystic Fibrosis Transmembrane Conductance Regulator Function with Clinical Features to Inform Precision Treatment of Cystic Fibrosis

Allison F. McCague et al.

AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2019)

Article Critical Care Medicine

Effects of an Antioxidant-enriched Multivitamin in Cystic Fibrosis A Randomized, Controlled, Multicenter Clinical Trial

Scott D. Sagel et al.

AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2018)

Article Critical Care Medicine

Vitamin C: The next step in sepsis management?

J. Teng et al.

JOURNAL OF CRITICAL CARE (2018)

Article Respiratory System

Bronchodilators in cystic fibrosis: a critical analysis

Peter J. Barry et al.

EXPERT REVIEW OF RESPIRATORY MEDICINE (2017)

Article Respiratory System

Doxycycline improves clinical outcomes during cystic fibrosis exacerbations

Xin Xu et al.

EUROPEAN RESPIRATORY JOURNAL (2017)

Article Respiratory System

Pancreatic insufficiency in Cystic Fibrosis

Vikesh K. Singh et al.

Journal of Cystic Fibrosis (2017)

Review Medicine, General & Internal

Vitamin E supplementation in people with cystic fibrosis (Review)

Peter O. Okebukola et al.

COCHRANE DATABASE OF SYSTEMATIC REVIEWS (2017)

Editorial Material Respiratory System

Optimising treatment of CF pulmonary exacerbation: a tough nut to crack

Sonya L. Heltshe et al.

THORAX (2016)

Review Medicine, General & Internal

Origins of Cystic Fibrosis Lung Disease

David A. Stoltz et al.

NEW ENGLAND JOURNAL OF MEDICINE (2015)

Article Respiratory System

Oxidative stress in stable cystic fibrosis patients: Do we need higher antioxidant plasma levels?

Antonela Lezo et al.

JOURNAL OF CYSTIC FIBROSIS (2013)

Review Biochemistry & Molecular Biology

Oxidative stress and antioxidant therapy in cystic fibrosis

Francesco Galli et al.

BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE (2012)

Article Clinical Neurology

Ataxia with vitamin E deficiency: update of molecular diagnosis

I. Di Donato et al.

NEUROLOGICAL SCIENCES (2010)

Article Critical Care Medicine

Cystic Fibrosis Pulmonary Guidelines Treatment of Pulmonary Exacerbations

Patrick A. Flume et al.

AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2009)

Review Respiratory System

Neutrophils in cystic fibrosis

D. G. Downey et al.

THORAX (2009)

Article Biochemistry & Molecular Biology

Exhaled 8-isoprostane and prostaglandin E2 in patients with stable and unstable cystic fibrosis

Vincenzina Lucidi et al.

FREE RADICAL BIOLOGY AND MEDICINE (2008)

Review Genetics & Heredity

Abetalipoproteinemia: two case reports and literature review

Rola Zamel et al.

ORPHANET JOURNAL OF RARE DISEASES (2008)

Article Gastroenterology & Hepatology

Vitamins a and e and pulmonary exacerbations in patients with cystic fibrosis

Fahed Hakim et al.

JOURNAL OF PEDIATRIC GASTROENTEROLOGY AND NUTRITION (2007)

Article Cardiac & Cardiovascular Systems

Use of dietary supplements among United States adults with coronary artery disease and atherosclerotic risks

Catherine Buettner et al.

AMERICAN JOURNAL OF CARDIOLOGY (2007)

Article Gastroenterology & Hepatology

Bioavailability of a novel, water-soluble vitamin E formulation in malabsorbing patients

Konstantinos Papas et al.

DIGESTIVE DISEASES AND SCIENCES (2007)

Review Biochemistry & Molecular Biology

Antioxidants in cystic fibrosis - Conclusions from the CF antioxidant workshop, Bethesda, Maryland, November 11-12, 2003

Andre M. Cantin et al.

FREE RADICAL BIOLOGY AND MEDICINE (2007)

Article Pediatrics

Vitamin E status in children with cystic fibrosis and pancreatic insufficiency

Shirley H. Huang et al.

JOURNAL OF PEDIATRICS (2006)

Article Nutrition & Dietetics

Associations of vitamin C status, fruit and vegetable intakes, and markers of inflammation and hemostasis

SG Wannamethee et al.

AMERICAN JOURNAL OF CLINICAL NUTRITION (2006)

Article Biochemistry & Molecular Biology

Faster plasma vitamin E disappearance in smokers is normalized by vitamin C supplementation

RS Bruno et al.

FREE RADICAL BIOLOGY AND MEDICINE (2006)

Article Biochemistry & Molecular Biology

Vitamin E delivery to human skin:: Studies using deuterated α-tocopherol measured by apci LC-MS

H Vaule et al.

FREE RADICAL BIOLOGY AND MEDICINE (2004)

Article Nutrition & Dietetics

Antioxidant deficiency in cystic fibrosis: when is the right time to take action?

EI Back et al.

AMERICAN JOURNAL OF CLINICAL NUTRITION (2004)

Article Respiratory System

Potential for antioxidant therapy of cystic fibrosis

AM Cantin

CURRENT OPINION IN PULMONARY MEDICINE (2004)

Article Nutrition & Dietetics

Oxidative stress in cystic fibrosis: Dietary and metabolic factors

LG Wood et al.

JOURNAL OF THE AMERICAN COLLEGE OF NUTRITION (2001)